52 related articles for article (PubMed ID: 31331239)
1. Predictive Value of First Posttreatment Imaging Using Standardized Reporting in Head and Neck Cancer.
Hsu D; Chokshi FH; Hudgins PA; Kundu S; Beitler JJ; Patel MR; Aiken AH
Otolaryngol Head Neck Surg; 2019 Dec; 161(6):978-985. PubMed ID: 31331239
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Performance of Response Assessment FDG-PET/CECT in HNSCC Treated With Definitive Radio(chemo)therapy Using NI-RADS.
Paul S; Gupta T; Purandare N; Joshi K; Ghosh-Laskar S; Budrukkar A; Swain M; Sinha S; Kumar A; Joshi A; Prabhash K; Nair S; Rangarajan V; Agarwal JP
Otolaryngol Head Neck Surg; 2023 Oct; 169(4):938-947. PubMed ID: 36856038
[TBL] [Abstract][Full Text] [Related]
3. Response assessment of post-treatment head and neck cancers to determine further management using NI-RADS (Neck Imaging Reporting and Data System): a subgroup analysis of a randomized controlled trial.
Mahajan A; Unde H; Sable NP; Shukla S; Vaish R; Patil V; Agarwal U; Agrawal A; Noronha V; Joshi A; Kapoor A; Menon N; Agarwal JP; Laskar SG; Dcruz AK; Chaturvedi P; Pai P; Rane SU; Bal M; Patil A; Prabhash K
Front Oncol; 2023; 13():1200366. PubMed ID: 37810970
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of NI-RADS for prediction of head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Li W; Sun Y; Shang W; Xu H; Zhang H; Lu F
Radiol Med; 2024 Jan; 129(1):70-79. PubMed ID: 37904037
[TBL] [Abstract][Full Text] [Related]
5. Posttreatment Head and Neck Cancer Imaging: Anatomic Considerations Based on Cancer Subsites.
Hiyama T; Miyasaka Y; Kuno H; Sekiya K; Sakashita S; Shinozaki T; Kobayashi T
Radiographics; 2024 Mar; 44(3):e230099. PubMed ID: 38386602
[TBL] [Abstract][Full Text] [Related]
6. Neck Imaging Reporting and Data System: More Than Just a Template.
Rhyner PA; Bhatt AA; Baugnon KL; Aiken AH
AJNR Am J Neuroradiol; 2022 Oct; 43(10):1400-1402. PubMed ID: 36574331
[TBL] [Abstract][Full Text] [Related]
7. Surveillance Imaging with PET/CT and CT and/or MRI for Head and Neck Cancer and Mortality: A Population-based Study.
Anzai Y; Chang CP; Rowe K; Snyder J; Deshmukh V; Newman M; Fraser A; Smith K; Date A; Galvao C; Monroe M; Hashibe M
Radiology; 2023 Apr; 307(2):e212915. PubMed ID: 36625743
[TBL] [Abstract][Full Text] [Related]
8. Effect of distance of treatment center on survival for HPV-negative head and neck cancer patients.
Farquhar DR; Masood MM; Lenze NR; Tasoulas J; Sheth S; Lumley C; Blumberg J; Yarbrough WG; Zevallos J; Weissler MC; Zanation AM; Hackman TG; Olshan AF
Head Neck; 2023 Dec; 45(12):2981-2989. PubMed ID: 37767817
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Head-and-Neck Molecular Imaging Reporting and Data System Criterion in Head-and-Neck Squamous Cell Carcinoma PostConcurrent Chemoradiotherapy.
Gupta M; Jajodia A; Ahlawat P; Gairola M; Agarwal M; Goyal S; Mehta P; Choudhury PS
Indian J Nucl Med; 2023; 38(4):334-339. PubMed ID: 38390552
[TBL] [Abstract][Full Text] [Related]
10. Value of Adherence to Posttreatment Follow-Up Guidelines for Head and Neck Squamous Cell Carcinoma.
Stone A; Liu J; Lin J; Schiff BA; Ow TJ; Mehta V; Smith RV
Laryngoscope; 2024 Feb; 134(2):708-716. PubMed ID: 37493178
[TBL] [Abstract][Full Text] [Related]
11. Osteoradionecrosis versus Cancer Recurrence: An Unresolved Clinical Dilemma.
Tufano-Sugarman AM; Wang KY; Kohn N; Ghaly M; Parashar B; Frank D; Kamdar D; Pereira L; Fantasia J; Seetharamu N
ORL J Otorhinolaryngol Relat Spec; 2023; 85(1):28-35. PubMed ID: 36455537
[TBL] [Abstract][Full Text] [Related]
12. Standardized reporting systems for (which?) brain tumors from in the dark: cons of the BT-RADS.
MartÃn-Noguerol T; Cabrera-Zubizarreta A; Luna A
Eur Radiol; 2024 Apr; ():. PubMed ID: 38583125
[No Abstract] [Full Text] [Related]
13. Standardized brain tumor reporting in the multidisciplinary spotlight: pros of the BT-RADS.
Ramos A; Hilario A
Eur Radiol; 2024 Apr; ():. PubMed ID: 38583126
[No Abstract] [Full Text] [Related]
14. Neck Imaging Reporting and Data System: Principles and Implementation.
Hsu D; Juliano AF
Neuroimaging Clin N Am; 2020 Aug; 30(3):369-377. PubMed ID: 32600637
[TBL] [Abstract][Full Text] [Related]
15. Retrospective Evaluation of NI-RADS for Detecting Postsurgical Recurrence of Oral Squamous Cell Carcinoma on Surveillance CT or MRI.
Dinkelborg P; Ro SR; Shnayien S; Schaafs LA; Koerdt S; Kreutzer K; Heiland M; Hamm B; Elsholtz FHJ
AJR Am J Roentgenol; 2021 Jul; 217(1):198-206. PubMed ID: 32876497
[No Abstract] [Full Text] [Related]
16. Radiomic biomarkers of locoregional recurrence: prognostic insights from oral cavity squamous cell carcinoma preoperative CT scans.
Ling X; Alexander GS; Molitoris J; Choi J; Schumaker L; Tran P; Mehra R; Gaykalova D; Ren L
Front Oncol; 2024; 14():1380599. PubMed ID: 38715772
[TBL] [Abstract][Full Text] [Related]
17. Reconstructive flap surgery in head and neck cancer patients: an interdisciplinary view of the challenges encountered by radiation oncologists in postoperative radiotherapy.
Thariat J; Carsuzaa F; Beddok A; Deneuve S; Marcy PY; Merlotti A; Dejean C; Devauchelle B
Front Oncol; 2024; 14():1379861. PubMed ID: 38665951
[TBL] [Abstract][Full Text] [Related]
18. Radiomic Biomarkers of Locoregional Recurrence: Prognostic Insights from Oral Cavity Squamous Cell Carcinoma preoperative CT scans.
Ren L; Ling X; Alexander G; Molitoris J; Choi J; Schumaker L; Mehra R; Gaykalova D
Res Sq; 2024 Jan; ():. PubMed ID: 38343846
[TBL] [Abstract][Full Text] [Related]
19. Performance of Neck Imaging Reporting and Data System (NI-RADS) for Diagnosis of Recurrence of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
Baba A; Kurokawa R; Kurokawa M; Yanagisawa T; Srinivasan A
AJNR Am J Neuroradiol; 2023 Oct; 44(10):1184-1190. PubMed ID: 37709352
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
